ALB and cancer: In fully adjusted models (model 3: model 2 + adjusted by vitamin C, ALP, ALB, SCR, and NFS scores), those with diabetes had a 42.7% (HRs: 1.427, 95% CIs: 1.256–1.621, p < 0.001), 45.8% (HRs: 1.458, 95% CIs: 1.117–1.902, p = 0.005), 42.3% (HRs: 1.423, 95% CIs: 1.229–1.647, p < 0.001), and 58.4% (HRs: 1.584, 95% CIs: 1.368–1.835, p < 0.001) higher risk of all-cause mortality, cardiovascular mortality, non-cardiovascular-related mortality, and non-cancer-related mortality, respectively, than patients DM.